Skip to main content

Table 2 Univariate and multivariate analysis associated with OS and DFS (n = 304)

From: NAP1L1 is a prognostic biomarker and contribute to doxorubicin chemotherapy resistance in human hepatocellular carcinoma

Variables

Overall survival

Disease-free survival

Univariate p value

Multivariable analysis

Univariate p value

Multivariable analysis

HR (95% CI)

p value

HR (95% CI)

p value

Age (years)

 < 50

      

 ≥ 50

0.241

  

0.246

  

Gender

 Female

      

 Male

0.965

  

0.352

  

HbsAg

 No

      

 Yes

0.910

  

0.343

  

AFP (ng/ml)

 < 400

      

 ≥ 400

0.079

 

n.a.

0.012

 

n.a.

Tumor size (cm)

 < 5.0

      

 ≥ 5.0

< 0.001

2.548 (1.799–3.607)

< 0.001

< 0.001

2.417 (1.755–3.328)

< 0.001

Tumor number

 Solitary

      

 Multiple

< 0.001

1.532 (1.061–2.212)

0.023

< 0.001

1.509 (1.054–2.159)

0.025

Microvascular invasion

 No

      

 Yes

< 0.001

3.160 (2.227–4.484)

< 0.001

< 0.001

1.973 (1.415–2.751)

< 0.001

NAP1L1 expression

 Low

      

 High

< 0.001

1.958 (1.391–2.755)

< 0.001

< 0.001

1.876 (1.373–2.565)

< 0.001